创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

胡光南, 张尊建, 宋瑞. 酚类化合物经UGTs代谢和药物相互作用的研究进展[J]. 药学进展, 2018, 42(3): 222-230.
引用本文: 胡光南, 张尊建, 宋瑞. 酚类化合物经UGTs代谢和药物相互作用的研究进展[J]. 药学进展, 2018, 42(3): 222-230.
HU Guangnan, ZHANG Zunjian, SONG Rui. Research Advances in Metabolism of Phenolic Compounds by UGTs and the Mediated Drug-drug Interactions[J]. Progress in Pharmaceutical Sciences, 2018, 42(3): 222-230.
Citation: HU Guangnan, ZHANG Zunjian, SONG Rui. Research Advances in Metabolism of Phenolic Compounds by UGTs and the Mediated Drug-drug Interactions[J]. Progress in Pharmaceutical Sciences, 2018, 42(3): 222-230.

酚类化合物经UGTs代谢和药物相互作用的研究进展

Research Advances in Metabolism of Phenolic Compounds by UGTs and the Mediated Drug-drug Interactions

  • 摘要: 由尿苷二磷酸葡萄糖醛酸转移酶(UGTs)介导的葡萄糖醛酸结合反应是多种内源性和外源性化合物在体内代谢、消除的重要途径。酚类化合物由于其多样的药理活性而受到广泛关注和研究,此类物质在体内易经UGTs代谢,生物利用度低。综述近年来酚类化合物经UGTs代谢及由UGTs介导的药物相互作用的研究进展。

     

    Abstract: Glucuronidation mediated by UDP-glucuronosyltransferases (UGTs) is an important pathway for the metabolism and elimination of numerous endobiotics and xenobiotics. Phenolics have attracted intensive attention and investigations due to its diverse pharmacological activities, whose extensive glucuronidation usually results in poor oral bioavailability and insufficient efficacy. This paper reviewed the advances in metabolism of phenolic compounds by UGTs and the mediated drug-drug interactions.

     

/

返回文章
返回